Impaired lipid metabolism in idiopathic pulmonary alveolar proteinosis

Restoration of PPARγ reverses lipid accumulation in alveolar macrophages of GM-CSF knockout mice

(2010) Anagha Malur et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Inhaled Granulocyte/Macrophage–Colony Stimulating Factor as Therapy for Pulmonary Alveolar Proteinosis

(2010) Ryushi Tazawa et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Quantitative Analysis of Longitudinal Response to Aerosolized Granulocyte-Macrophage Colony-Stimulating Factor in Two Adolescents With Autoimmune Pulmonary Alveolar Proteinosis

(2009) Terry E. Robinson et al.   CHEST

Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management

(2009) Isham Huizar et al.   CURRENT OPINION IN PULMONARY MEDICINE

Effect of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study

(2009) Robert R Henry et al.   LANCET

Human GM-CSF Autoantibodies and Reproduction of Pulmonary Alveolar Proteinosis

(2009) Takuro Sakagami et al.   NEW ENGLAND JOURNAL OF MEDICINE

Characteristics of a Large Cohort of Patients with Autoimmune Pulmonary Alveolar Proteinosis in Japan

(2008) Yoshikazu Inoue et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Eicosanoid Lipid Mediators in Fibrotic Lung Diseases

(2008) Steven K. Huang et al.   CHEST

Insulin resistance in pulmonary arterial hypertension

(2008) R. T. Zamanian et al.   EUROPEAN RESPIRATORY JOURNAL